Benzinga | Jun 22, 2021 07:40AM EDT

OPKO's BioReference Laboratories Announces COVID-19 Testing Program For Royal Caribbean Group

MIAMI, June 22, 2021 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced a COVID-19 testing program for U.S. based crew and guests who cruise with Royal Caribbean Group, helping provide a safe environment for travelers.